Riskpilot← Back to searchSign inGet full access10x Genomics Denmark ApS
APSActiveCVR 40243224Lyngbyvej 20Manufacture of pharmaceutical preparations · NACE 2120Est. 20192 employees
Revenue 2024
DKK 3,4M
+66% vs 2023
EBITDA margin
7.9%
+147% vs 2023
Equity ratio
57.2%
Financial strength
Net profit 2024
DKK 183K
+131% vs 2023
| Revenue | DKK 3,4M | +66% |
| EBITDA | DKK 269K | +147% |
| Net profit | DKK 183K | +131% |
| Total assets | DKK 1,4M | -39% |
| Equity | DKK 819K | +29% |
| Employees | 2 | — |
Legal name
10x Genomics Denmark ApS
CVR number
40243224
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
31. januar 2019
Share capital
DKK 51.590
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Company purpose
Selskabets formål er at fremstille og sælge instrumenter og forbrugsmaterialer til kunder, der beskæftiger sig med forsknings- og udviklingsaktiviteter inden for bioteknologi, liv og medicinsk videnskab.
Address
Lyngbyvej 20
Email
gc@10xgenomics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 552 | -1.602 | 52.191 | 7.334 | 2.059 | 3.416 |
| Staff expenses | -226 | -944 | -5.032 | -6.373 | -2.524 | -3.147 |
| EBITDA | 326 | -2.547 | 47.159 | 960 | -574 | 269 |
| Depreciation & amort. | -0 | -24 | -32 | -66 | -17 | -0 |
| EBIT | 326 | -2.571 | 47.126 | 894 | -591 | 269 |
| Net financials | -7 | -39 | 3.802 | 2.779 | 35 | -33 |
| Profit before tax | 319 | -2.609 | 50.929 | 3.673 | -556 | 236 |
| Tax | 74 | -582 | 11.125 | 853 | 30 | 53 |
| Net profit | 245 | -2.027 | 39.804 | 2.820 | -587 | 183 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 759 | 2.480 | 50.363 | 6.140 | 2.342 | 1.430 |
| Equity | 625 | -1.402 | 38.402 | 1.222 | 635 | 819 |
| Long-term debt | 134 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 3.881 | 11.950 | 4.914 | 1.707 | 611 |
| Total debt | 134 | 3.881 | 11.950 | 4.914 | 1.707 | 611 |
EBITDA margin
7.9%
This company
15.8%
Market median
-50% vs market
20192024
Equity ratio
57.2%
This company
38.2%
Market median
+50% vs market
20192024
Return on equity
22.4%
This company
18.4%
Market median
+22% vs market
20192024
Net profit margin
5.4%
This company
8.1%
Market median
-33% vs market
20192024
Asset turnover
2.39×
This company
1.12×
Market median
+113% vs market
20192024
Debt / equity
0.75×
This company
0.62×
Market median
+21% vs market
20192024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-31 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SN Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
SK Founder | Founder | 2019 | — | — |
ES Management | Management | 2021 | — | — |
JJ Management | Management | 2021 | — | — |
AS Management | Management | 2024 | — | — |
SH Founder | Founder | 2019 | — | — |
JS Management | Management | 2025 | — | — |
JH Founder | Founder | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of 10x Genomics Denmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren Nyboe Jakobsen | Chief Executive Officer | 0 companies |
| Sunil Kumar Saini | Founder | 0 companies |
| Eric Stewart Whitaker | Management | 0 companies |
| Justin John McAnear | Management | 0 companies |
| Adam Samuel Taich | Management | 0 companies |
| Sebastian Hartmut Springer | Founder | 0 companies |
| James Sears Bryant | Management | 0 companies |
| JCBS Holding GmbH | Founder | 0 companies |
| Søren Fogh Aagaard | Board of Directors | 0 companies |